Listened to Bourla talk at the conference. He said, among other things, that PFE's pipeline is doing better than expectations. He also said that PFE will continue to monitor the variants and be ready to adapt quickly if necessary. He said that PFE and BNTX are good partners, and he believes they will continue to work together on some projects. He went on to say that the billions from the vaccine and COVID treatment are allowing PFE to seek out early-stage biotechs that will provide the opportunity to lead to a stronger approved drug line when PFE begins to lose some patents in the 25 to 30 year period. Bourla said PFE has become very smart and nimble is seeking out strategic opportunities. $Pfizer(PFE)$